ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00332969
Recruitment Status : Completed
First Posted : June 2, 2006
Last Update Posted : March 31, 2017
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )